The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: A multicenter, double-blind, randomized trial

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 2, 2008, Pages 321-328

  Tabbutt, Sarah ^a   Nicolson, Susan C ^a   Adamson, Peter C ^a   Zhang, Xuemei ^a   Hoffman, Marc L ^g   Wells, Winfield ^b   Backer, Carl L ^c   McGowan, Francis X ^d   Tweddell, James S ^e   Bokesch, Paula ^f   Schreiner, Mark ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESMOLOL;

AGE DISTRIBUTION; AORTA COARCTATION; AORTA SURGERY; ARTICLE; BLOOD PRESSURE REGULATION; BRADYCARDIA; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; INFANT; INJECTION SITE REACTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; WHEEZING;

ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; AORTIC COARCTATION; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; INFANT; INFANT, NEWBORN; MALE; POSTOPERATIVE COMPLICATIONS; PROPANOLAMINES;

EID: 48649095538     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.09.086     Document Type: Article

References (19)

1. Samanek M., Slavik Z., Zborilova B., Hrobonova V., Voriskova M., and Skovranek J. Prevalence, treatment and outcome of heart disease in live-born children: a prospective analysis of 91,823 live-born children. Pediatr Cardiol 10 (1989) 205-211
2. Wood A.E., Javadpour H., Duff D., Oslizlok P., and Walsh K. Is extended arch aortoplasty the operation of choice for infant coarctation? Results of 15 years' experience in 181 patients. Ann Thorac Surg 77 (2004) 1353-1358
3. Wright G.E., Nowak C.A., Goldberg C.S., Ohye R.G., Bove E.L., and Rocchini A.P. Extended resection and end-to-end anastomosis for aortic coarctation in infants: results of a tailored surgical approach. Ann Thorac Surg 80 (2005) 1453-1459
4. Sealey W.C. Paradoxical hypertension after repair of coarctation of the aorta: a review of its causes. Ann Thorac Surg 50 (1990) 323-329
5. Rocchini A.P., Rosenthal A., Barger A.C., Castaneda A.R., and Nadas A.S. Pathogenesis of paradoxical hypertension after coarctation resection. Circulation 54 (1976) 382-387
6. Gidding S.S., Rocchini A.P., Beekman R., Szpunar C.A., Moorehead C., Behrendt D., et al. Therapeutic effect of propranolol on paradoxical hypertension after repair of coarctation of the aorta. N Engl J Med 312 (1985) 1224-1228
7. Angaran D.M., Schultz N.J., and Tschida V.H. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent. Clin Pharm 5 (1986) 288-303
8. Cuneo B.F., Zales V.R., Blahunka P.C., and Benson D.W. Pharmacodynamics and pharmacokinetics of esmolol, a short-acting beta-blocking agent, in children. Pediatr Cardiol 15 (1994) 296-301
9. Wiest D.B., Garner S.S., Uber W.E., and Sade R.M. Esmolol for the management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg 115 (1998) 890-897
10. Smerling A., and Gersony W.M. Esmolol for severe hypertension following repair of aortic coarctation. Crit Care Med 18 (1990) 1288-1290
11. Vincent R.N., Click L.A., Willliams H.M., Plauth W.H., and Williams W.H. Esmolol as an adjunct in the treatment of systemic hypertension after operative repair of coarctation of the aorta. Am J Cardiol 65 (1990) 941-943
12. Zuppa A.F., Shi H., and Adamson P.C. Liquid chromatography-electrospray mass spectrometry (LC-MS) method for determination of esmolol concentration in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 792 (2003) 203-301
13. Cowley C.G., Orsmond G.S., Feola P., McQuillan L., and Shaddy R.E. Long-term, randomized comparison of balloon angioplasty and surgery for native coarctation of the aorta in childhood. Circulation 111 (2005) 3453-3456
14. Walhout R.J., Lekkerkerker J.C., Oron G.H., Bennink G.B.W.E., and Meijboom E.J. Comparison of surgical repair with balloon angioplasty for native coarctation in patients from 3 months to 16 years of age. Eur J Cardiothorac Surg 25 (2004) 722-727
15. Vogt M., Kuhn A., Baumgartner D., Baumgartner C., Busch R., Kostolny M., et al. Impaired elastic properties of the ascending aorta in newborns before and early after successful coarctation repair. Proof of a systemic vascular disease of the prestenotic arteries. Circulation 111 (2005) 3269-3273
16. Polson J.W., McCallion N., Waki H., Thorne G., Tooley M.A., Paton J.F.R., et al. Evidence of cardiovascular autonomic dysfunction in neonates with coarctation of the aorta. Circulation 113 (2006) 2844-2850
17. Reynolds R.D., Gorczynski R.J., and Quon C.Y. Pharmacology and pharmacokinetics of esmolol. J Clin Pharmacol 26A (1986) A3-A14
18. Wiest D.B., Trippel D.L., Gillette P.C., and Garner S.S. Pharmacokinetics of esmolol in children. Clin Pharmacol Ther 49 (1991) 618-623
19. Adamson P.C., Rhodes L.A., Saul J.P., Dick M., Epstein M.R., Moate P., et al. The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias. Pediatr Cardiol 27 (2006) 420-427